A multigene test for breast cancer recurrence risk was used in a minority of eligible patients, yet was associated with a decrease in chemotherapy use.
Tracy A. Lieu, MD, MPH
Advertisement
Articles by Tracy A. Lieu, MD, MPH
When preventive care was exempt from the deductible, well-child visits did not change for children switching from traditional plans to high-deductible plans.
Advertisement
Latest Updated Articles
- Breast Cancer Multigene Testing Trends and Impact on Chemotherapy Use
Published: May 17th 2016 | Updated:
- Immunization Status Among Children Newly Enrolled in a Health Plan: A New Frontier for Quality Measurement?
Published: February 1st 2003 | Updated:
- Use of Well-Child Visits in High-Deductible Health Plans
Published: November 19th 2010 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Pulling Back Funding for Research Could Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
3
Value-Based Care Interventions and Management of CKD Progression
4
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
5
